샘플 요청 목록

 카트 문의
시장보고서
상품코드
1513944

연구용 ELISA(효소 결합 면역흡착 측정법) 시장

Research ELISA (Enzyme-Linked Immunosorbent Assay)
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 266 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

연구용 ELISA(효소 결합 면역흡착 측정법) 세계 시장은 2030년까지 6억 9,230만 달러에 달할 전망

2023년에 5억 3,820만 달러로 추정되는 연구용 ELISA(효소 결합 면역흡착 측정법) 세계 시장은 분석 기간 2023-2030년에 CAGR 3.7%로 성장하여 2030년에는 6억 9,230만 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 ELISA 키트는 CAGR 3.5%로 성장을 지속하고, 분석 기간 종료 시 4억 7,860만 달러에 달할 것으로 예측됩니다. ELISA 개발 세트 및 항체 쌍 부문은 분석 기간 동안 CAGR 4.1%에서 성장할 것으로 추정됩니다.

미국 시장은 1억 4,560만 달러로 추정, 중국은 CAGR 6.1%로 성장 예측

미국의 연구용 ELISA(효소 결합 면역흡착 측정법) 시장은 2023년에 1억 4,560만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 1억 4,020만 달러 규모에 이를 것으로 예측되며, 분석 기간 2023-2030년의 CAGR은 6.1%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.0%와 3.0%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 2.4%로 성장할 것으로 예측됩니다.

세계의 연구용 ELISA(효소 결합 면역흡착 측정법) 시장- 주요 동향과 촉진요인 정리

효소 결합 면역흡착 측정법(ELISA)은 널리 이용되고 있는 분석 생화학 검정이며, 펩티드, 단백질, 항체, 호르몬 등의 물질을 검출·정량하기 위해서 설계되고 있습니다. 이 분석은 항체의 특이성을 이용하여 복잡한 샘플에서 특정 생체 분자의 존재를 검출합니다. ELISA는 항원 항체 상호작용의 원리에 기초하며, 효소 결합 항원 또는 항체는 표적 분자의 존재하에 측정가능한 신호(보통 색 변화)를 생성합니다. 이 기술은 임상 진단, 식품 안전, 환경 모니터링 등 다양한 분야의 진단, 품질 관리, 연구에 널리 응용되고 있습니다.

ELISA의 견고성과 범용성은 매우 특이적이고 민감한 결과를 제공하는 능력에 기인하며 임상과 연구 모두에서 필수적입니다. 임상 진단에서 ELISA는 바이러스 및 박테리아 감염,자가 면역 질환, 알레르기 등의 질병 검출에 매우 중요합니다. 예를 들어, HIV, 간염, SARS-CoV-2의 검출에 자주 사용됩니다. 식품 산업에서 ELISA는 알레르겐, 독소 및 오염 물질을 감지하여 식품의 안전을 보장하는 데 도움이 됩니다. 또한 환경기관에서는 물이나 토양의 오염물질과 병원체를 모니터링하기 위해 ELISA를 채용하고 있습니다. 직접법, 간접법, 샌드위치법, 경쟁 ELISA 등, 각각 특정 분석 요구에 맞는 다양한 형식이 개발됨으로써, 분석의 적응성은 더욱 높아지고 있습니다.

연구용 ELISA 시장의 성장은 기술 진보, 만성 질환 및 감염의 유행, 비용 효율적이고 신뢰할 수 있는 진단 방법에 대한 수요 증가 등 여러 요인으로 인해 발생합니다. 자동화된 고처리량 ELISA 시스템 개발과 같은 기술 혁신으로 분석의 효율성과 정확성이 크게 향상되었습니다. 암이나 당뇨병과 같은 만성 질환의 급증은 신흥 감염과 함께 정밀 진단 도구의 필요성을 증폭시켜 ELISA에 대한 수요를 끌어 올리고 있습니다. 게다가, 맞춤형 의료를 위한 경향 증가와 의약품 개발 및 치료 반응 모니터링에 있어서의 ELISA의 응용 확대가 시장의 성장을 더욱 뒷받침하고 있습니다. 식품과 환경의 안전성에 대한 의식 증가와 규제의 중시도 ELISA 시장의 확대에 기여하고 있습니다.

조사 대상 기업 예(총 27건)

  • American Laboratory Products Company(ALPCO)(US)
  • BD Biosciences(US)
  • BioLegend, Inc.(US)
  • Bio-Rad Laboratories, Inc.(US)
  • Enzo Life Sciences, Inc.(US)
  • Merck KGaA
  • Mercodia AB(Sweden)
  • R&D Systems, Inc.(US)
  • Thermo Fischer Scientific Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

JHS 24.07.24

Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market to Reach US$692.3 Million by 2030

The global market for Research ELISA (Enzyme-Linked Immunosorbent Assay) estimated at US$538.2 Million in the year 2023, is expected to reach US$692.3 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$478.6 Million by the end of the analysis period. Growth in the ELISA Development Sets & Antibody Pairs segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$145.6 Million While China is Forecast to Grow at 6.1% CAGR

The Research ELISA (Enzyme-Linked Immunosorbent Assay) market in the U.S. is estimated at US$145.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$140.2 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market - Key Trends and Drivers Summarized

Enzyme-Linked Immunosorbent Assay (ELISA) is a widely utilized analytical biochemistry assay, designed for detecting and quantifying substances such as peptides, proteins, antibodies, and hormones. This assay leverages the specificity of antibodies to detect the presence of specific biomolecules in complex samples. ELISA operates on the principle of antigen-antibody interactions, where an enzyme-linked antigen or antibody produces a measurable signal, typically a color change, in the presence of its target molecule. This technique has found extensive applications in diagnostics, quality control, and research across various fields including clinical diagnostics, food safety, and environmental monitoring.

ELISA's robustness and versatility stem from its ability to deliver highly specific and sensitive results, making it indispensable in both clinical and research settings. In clinical diagnostics, ELISA is crucial for disease detection, including viral and bacterial infections, autoimmune diseases, and allergies. For instance, it is commonly used in the detection of HIV, hepatitis, and SARS-CoV-2. In the food industry, ELISA helps ensure food safety by detecting allergens, toxins, and contaminants. Moreover, environmental agencies employ ELISA to monitor pollutants and pathogens in water and soil. The assay's adaptability is further enhanced by the development of various formats, such as direct, indirect, sandwich, and competitive ELISA, each tailored for specific analytical needs.

The growth in the ELISA market is driven by several factors including advancements in technology, increasing prevalence of chronic and infectious diseases, and the rising demand for cost-effective and reliable diagnostic methods. Technological innovations, such as the development of automated and high-throughput ELISA systems, have significantly improved the efficiency and accuracy of the assays. The surge in chronic diseases like cancer and diabetes, alongside emerging infectious diseases, has amplified the need for precise diagnostic tools, thus boosting the demand for ELISA. Additionally, the growing trend towards personalized medicine and the expanding application of ELISA in drug development and monitoring therapeutic responses have further fueled market growth. The increasing awareness and regulatory emphasis on food and environmental safety also contribute to the expanding ELISA market, as these assays are vital for ensuring compliance with safety standards.

Select Competitors (Total 27 Featured) -

  • American Laboratory Products Company (ALPCO) (US)
  • BD Biosciences (US)
  • BioLegend, Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Enzo Life Sciences, Inc. (US)
  • Merck KGaA
  • Mercodia AB (Sweden)
  • R&D Systems, Inc. (US)
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Use of ELISA in Drug Discovery and Development Drives Adoption
    • Advancements in ELISA Technology Propel Growth in Research Applications
    • Growing Prevalence of Chronic and Infectious Diseases Spurs Demand for ELISA
    • Here's How Automation in ELISA Testing Drives Market Expansion
    • Adoption of ELISA in Environmental Monitoring Throws the Spotlight on Market Growth
    • Increasing Demand for Rapid and Point-of-Care Testing Spurs ELISA Market Growth
    • Growing Use of ELISA in Vaccine Development Expands Market Opportunities
    • Adoption of Multiplex ELISA Platforms Generates Demand in Research Settings
    • Increasing Number of Clinical Trials Using ELISA Drives Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for ELISA Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for ELISA Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for ELISA Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for ELISA Development Sets & Antibody Pairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for ELISA Development Sets & Antibody Pairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for ELISA Development Sets & Antibody Pairs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • JAPAN
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • CHINA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • EUROPE
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • FRANCE
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • GERMANY
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Spain 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Russia 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Australia 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • INDIA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: India 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: South Korea 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Argentina 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Brazil 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Mexico 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of Latin America 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Middle East 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Iran 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Israel 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Saudi Arabia 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: UAE 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Middle East 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • AFRICA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Africa 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제